Silver Book Fact

Tools to Prevent Secondary Osteoporosis Fractures are Not Being Used

Fact image

Hansen D, Bazell C, Pelizzari P, Pyenson B. Medicare Cost of Osteoporotic Fractures. Milliman Research Report. 2019; https://static1.squarespace.com/static/5c0860aff793924efe2230f3/t/5d76b949deb7e9086ee3d7dd/1568061771769/Medicare+Cost+of+Osteoporotic+Fractures+20190827.pdf

Reference

Title
Medicare Cost of Osteoporotic Fractures
Publication
Milliman Research Report
Publication Date
2019
Authors
Hansen D, Bazell C, Pelizzari P, Pyenson B
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value
  • Economic Value
  • Future Value

Related Facts

  • Teriparatide, or human recombinant PTH, has been shown to decrease vertebral fractures by 65% to 69%, and non-vertebral fragility fractures by around 53%.  
  • Teriparatide, or human recombinant PTH, has been shown to increase vertebral bone mineral density (BMD) by 9% to 13%.  
  • A meta-analysis of clinical trials found that calcium supplements reduced the risk of vertebral fractures by around 23%.  
  • 30 drugs are currently in development for osteoporosis.  
  • An increase in bone mineral density (BMD) testing and osteoporosis treatment was associated with a decrease in hip fracture incidence.